Singapore, Aug. 1 -- The Health Sciences Authority received information related to the study titled 'RASolute 303: A Phase 3 Global, Multicenter, Open-label, Randomized, 3-Arm Study of Daraxonrasib Mo... Read More
U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07739667) titled 'Blood Pressure Measurement Using Vitacam' on July 28. Brief Summary: The purpose of this cl... Read More
U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07738471) titled 'Assessment of Clinical Success of Custom-Made Versus Prefabricated Zirconia Crowns in Pulpot... Read More
Singapore, Aug. 1 -- The Health Sciences Authority received information related to the study titled 'A Multicenter, Multi-Part, Phase 1/2 Study of EIK1005 as Monotherapy and in Combination with Pembro... Read More
Singapore, Aug. 1 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-controlled, Multicenter, Parallel-group Study to Evalu... Read More
U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07740317) titled 'Neurocognitive Trajectories After BCMA CAR-T' on July 28. Brief Summary: The purpose of thi... Read More
Singapore, Aug. 1 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and ... Read More
Singapore, Aug. 1 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and ... Read More
U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07739836) titled 'Effects of Physical Use Characteristics During Academic Education on Musculoskeletal Functio... Read More
Singapore, Aug. 1 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Investigator and Participant Blinded, Single Ascending D... Read More